|
| Protein Name | Heat Shock 70 kDa Protein 1B |
| Gene | HSPA1B |
| UniProt | P0DMV8 |
| Molecular Weight | ~70 kDa |
| Subcellular Localization | Cytoplasm, Nucleus, Cell membrane |
| Protein Family | Hsp70 family (HSP70) |
| Aliases | HSP70-1B, HSP70-2, HSPA1B, Hsp70 |
HSPA1B (Heat Shock 70 kDa Protein 1B) is a stress-inducible molecular chaperone encoded by the HSPA1B gene. As a member of the Hsp70 family, HSPA1B is one of the most studied heat shock proteins due to its critical roles in protein homeostasis, stress protection, and cellular survival. HSPA1B is constitutively expressed at low levels but dramatically increases in response to various cellular stresses including heat, oxidative stress, and proteotoxic challenges. This protein has garnered significant attention in neurodegenerative disease research due to its ability to prevent protein aggregation and facilitate clearance of misfolded proteins [1].
HSPA1B has the characteristic domain structure of Hsp70 proteins:
¶ N-terminal ATPase Domain (~44 kDa)
- Binds and hydrolyzes ATP
- Regulates substrate binding cycle
- Contains the ATPase cassette
¶ Substrate-binding Domain (~25 kDa)
- Binds unfolded polypeptides
- Contains the peptide-binding cavity
- Regulated by lid structure
¶ C-terminal Lid Domain
- Covers substrate-binding pocket
- Allosterically regulates ATPase activity
- Essential for chaperone function
- EEVD motif at C-terminus (Hsp70 family signature)
- Multiple phosphorylation sites
- Can form multimers
HSPA1B functions as a molecular chaperone through its ATP-dependent cycle:
- Substrate recognition: Binds to hydrophobic regions of unfolded proteins
- Folding assistance: Facilitates proper protein folding
- Aggregation prevention: Prevents harmful protein aggregation
- Refolding: Can refold denatured proteins
As a stress-inducible protein:
- Heat shock response: Major effector of heat shock transcription factor
- Oxidative stress: Protects against reactive oxygen species
- Proteotoxic stress: Counteracts misfolded protein accumulation
HSPA1B participates in cellular protein homeostasis:
- Ubiquitin-proteasome system: Co-operates with E3 ubiquitin ligases
- Autophagy: Regulates aggrephagy and mitophagy
- ER-associated degradation (ERAD): Involved in clearing misfolded proteins
HSPA1B has anti-apoptotic properties:
- Inhibits caspase activation
- Blocks apoptosome formation
- Protects mitochondrial integrity
HSPA1B plays multiple protective roles in AD:
Amyloid-β handling:
- Binds to amyloid-β peptides [2]
- Facilitates Aβ clearance
- Protects against Aβ-induced toxicity
Tau pathology:
- Interacts with hyperphosphorylated tau
- May facilitate tau clearance
- Protects against tau-induced neurodegeneration
Neuronal protection:
- Anti-apoptotic effects
- Oxidative stress protection
- Mitochondrial protection
HSPA1B is particularly relevant to PD:
α-Synuclein management:
- Binds to alpha-synuclein [3]
- Inhibits α-synuclein aggregation
- Facilitates autophagic clearance
Mitochondrial function:
- Protects against mitochondrial toxins
- Maintains mitochondrial protein quality
- Supports mitophagy
Dopaminergic neuron survival:
- Protects dopaminergic neurons
- Upregulated in PD brains (compensatory)
HSPA1B involvement in ALS:
- Mutant SOD1 handling
- Stress granule dynamics
- Motor neuron protection
In Huntington's disease:
HSPA1B is a major therapeutic target:
Small molecules that increase HSPA1B expression:
- Geranylgeranylacetone (GGA): FDA-approved HSP inducer
- Arimoclomol: HSP co-inducer in clinical trials for ALS
- 17-DMAG: HSP90 inhibitor (indirect HSP70 inducer)
- AAV-mediated HSPA1B delivery
- Viral vector approaches
- Recombinant HSP70 administration
- Cell-permeable HSP70 variants
Key research developments:
- HSPA1B is upregulated in neurodegenerative disease brains
- Genetic variants of HSPA1B modify disease risk
- HSPA1B-based therapies show promise in animal models